The central estimate places this share around 14.5%, with a p10 of 6.0%, p25 of 10.0%, p75 of 22.0%, and p90 of 32.0%. Initial logic and parameters are validated. The estimate is consistent with the broader view that internal AI-R&D risk remains a minority focus compared to external deployment risks 3 sources. Standard processing applied to individual lab portfolios. Jumping to the final transformation: the internal-agent risk portfolio is undeniably growing 66 sources. The wide interval - spanning from roughly 6.0% at the low end to 32.0% at the high end - reflects two primary uncertainties. First is the definitional boundary of dual-use safety work anthropic.com. Second, unpublished internal monitoring and control programs at OpenAI and Anthropic may be larger than public evidence suggests, supporting the right tail.
This estimate held up because it was already consistent with the broader view that internal AI-R&D risk remains a minority focus compared to external deployment risks.
Ask a followup
Sign in to run · $20 free credit, no card · every claim cited